Bromide

Bromide

SCHEMBL9691766

Fc1cc[n+](Cc2ccccc2)cc1.[Br-]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CHKA known ✓ P35790 8/20 0.58
▸ ACHE known ✓ P22303 2/20 0.47
▸ ALDH1A1 P00352 3/20 0.58
▸ LMNA P02545 3/20 0.58
▸ HTT P42858 2/20 0.58
▸ SMN1; SMN2 Q16637 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ F2 P00734 1/20 0.45
▸ PRSS1 P07477 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10692064 0.98 CHKA (0.57) CHKAALDH1A1LMNAHTTSMN1; SMN2
Benzyl Viologen SCHEMBL4079047 0.82 ALDH1A1 (0.71) CHKAALDH1A1LMNAHTTSMN1; SMN2
Bromide SCHEMBL365151 0.81 CHKA (0.61) CHKAALDH1A1LMNAHTTSMN1; SMN2
Bromide SCHEMBL28611338 0.81 CHKA (0.61) CHKAALDH1A1LMNAHTTSMN1; SMN2
Bromide SCHEMBL10601001 0.81 CHKA (0.45) CHKAALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL13283227 0.81 CHKA (0.61) CHKAALDH1A1LMNAHTTSMN1; SMN2
Bromide SCHEMBL5206067 0.80 ALDH1A1 (0.62) CHKAALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL30826134 0.80 BCHE (0.53) CHKAALDH1A1LMNAHTTSMN1; SMN2
Bromide SCHEMBL8890844 0.80 CHKA (0.64) CHKAALDH1A1LMNAHTTSMN1; SMN2
Benzyl Viologen SCHEMBL1108041 0.79 ALDH1A1 (0.74) CHKAALDH1A1LMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5137884-A Antibiotics MERCK & CO., INC. (US) 1992-08-11 — — US disclosed
US-4695565-A Antibacterial 7β-heterocyclic-cephem MERCK & CO., INC. (US) 1987-09-22 — — US disclosed
EP-0021082-B1 N-HETEROCYCLYL THIENAMYCINS, PROCESS FOR PREPARING AND ANTIBIOTIC PHARMACEUTICAL COMPOSITION CONTAINING THE SAME MERCK & CO. INC. (US) 1987-08-12 — — EP disclosed
EP-0018595-B1 7-N-HETEROCYCLYL CEPHALOSPORINS, A PROCESS FOR PREPARING AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME MERCK & CO. INC. (US) 1986-08-20 — — EP disclosed
EP-0177897-A2 Antibacterial 7beta-heterocyclic-cephem MERCK & CO. INC. (US) 1986-04-16 — — EP disclosed
US-4376774-A CONTAINING A PYRIDINIUM RING MERCK & CO., INC. (US) 1983-03-15 — — US disclosed
US-4358447-A ZWITTERIONS MERCK & CO., INC. (US) 1982-11-09 — — US disclosed
US-4283397-A 7-N-Heterocyclyl cephalosporins and antibiotic pharmaceutical compositions containing them MERCK & CO., INC. (US) 1981-08-11 — — US disclosed
US-4282219-A 7-N-Heterocyclyl cephalosporins and antibiotic pharmaceutical compositions containing them MERCK & CO., INC. (US) 1981-08-04 — — US disclosed
US-4271159-A ANTIBIOTICS MERCK & CO., INC. (US) 1981-06-02 — — US disclosed
US-4255424-A ANTIBIOTICS MERCK & CO., INC. (US) 1981-03-10 — — US disclosed
EP-0021082-A1 N-heterocyclyl thienamycins, process for preparing and antibiotic pharmaceutical composition containing the same MERCK & CO. INC. (US) 1981-01-07 — — EP disclosed
EP-0018595-A2 7-N-Heterocyclyl cephalosporins, a process for preparing and a pharmaceutical composition comprising the same MERCK & CO. INC. (US) 1980-11-12 — — EP disclosed
Send feedback